A study of Microbiome-based therapy for the treatement of intrahepatic cholestasis of pregnancy.
Phase of Trial: Phase I
Latest Information Update: 19 Dec 2016
At a glance
- Drugs Cholestasis-microbiome-based-therapy (Primary)
- Indications Intrahepatic cholestasis
- Focus Adverse reactions
- 19 Dec 2016 New trial record
- 08 Dec 2016 According to a Ferring Pharmaceuticals media release, the recruitment of patients for this study begun on 6 December 2016.
- 05 Dec 2016 According to a Ferring Pharmaceuticals media release, recruitment of patients will begin on December 6, 2016 and will be conducted in cooperation with the Women's Clinic in Lund, Sweden.